We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Often drawing support from its investigations, litigation, and regulatory teams, A&O Shearman houses a broad offering known for its strength in SPC disputes within the pharma industry and strategic M&A. The group also has broad expertise spanning post-M&A cases, divestments, and patent infringement actions. Laëtitia Bénard leads the team and is recommended for her vast experience in multi-jurisdictional patent disputes within the life sciences sector, often representing pharma companies. Charles Tuffreau is well equipped to handle preliminary injunction proceedings and cases concerning patent infringement and validity.
Legal 500 Editorial commentary
Key clients
- Ipsen
- ABF Ingredients
Abbreviated data is displayed for this firm.
Work highlights
- Representing a global pharma and healthcare client in patent actions before the Paris First Instance Court, the Paris Court of Appeals, and the Supreme Court concerning the validity and enforcement against major generic companies of its SPCs relating to the combination of ezetimibe and statins, in the field of the treatment of hypercholesterolemia.
- Representing a global pharma and healthcare client to defend its rights regarding its SPC covering the combination of sitagliptin and metformin for the treatment of diabetes.
Abbreviated data is displayed for this firm.